Starting next month, the major pharmaceutical provinces will include a large number of traditional Chinese medicine formula granules in medical insurance

【Pharmaceutical Network Industry News】Chinese medicine formula granules are an important part of traditional Chinese medicine, which is a "modern" product of traditional Chinese medicine, with the advantages of easy to take and easy to carry, and the market prospect is broad
.
At present, Chinese medicine formula granules are being accelerated to be included in medical insurance, further meeting the drug needs of the insured and reducing the burden of
related costs.
It is understood that under the guidance of the policy, since the beginning of this year, Anhui Province, Fujian Province and other implementation of some of the Chinese medicine formula granules into the local medical insurance notice, in addition, since November, there are provinces and cities to include a large number of Chinese medicine formula granules into the scope of
medical insurance.
Recently, the Hebei Provincial Medical Insurance Bureau issued a notice on the procurement of traditional Chinese medicine formula granules and medical insurance payment, and since November 1, Chinese medicine formula granules that meet national or provincial quality standards have begun to hang on the net
.
The notice proposes that the varieties of traditional Chinese medicine formula granules purchased by designated medical institutions in accordance with the provincial centralized drug procurement platform in accordance with the national or provincial quality standards, and corresponding to the traditional Chinese medicine tablets that have been included in the payment scope of the medical insurance fund, are included in the scope of medical insurance payment, and according to the category B management, the proportion of individual advance self-payment is uniformly determined to be 5%
in the province.
Designated medical institutions purchase at the lowest net price, which can be sold
by 15%.
The traditional Chinese medicine formula granules included in the scope of medical insurance payment shall be managed by the same name, and the production enterprises
shall not be distinguished.
In addition, it is clear that before October 31, medical institutions can purchase traditional Chinese medicine formula granules according to the current model of national or provincial quality standards, which are not included in the scope of
medical insurance payment.
Behind the local inclusion of traditional Chinese medicine formula granules in medical insurance, the process of industry standardization is accelerating
.
From November 1, 2021, the pilot work of Chinese medicine formula granules has officially ended, according to the regulations, Chinese medicine formula granules should be produced in accordance with the production process for the record, and comply with national drug standards
.
Where national drug standards are not provided, they shall comply with the standards
formulated by the provincial drug supervision and management departments.
In addition, the State Pharmacopoeia Commission combined with the pilot work experience to organize the examination and approval of national drug standards for traditional Chinese medicine formula granules, and published
them in batches.
After the promulgation and implementation of the national drug standards for Chinese medicine formula granules, the corresponding standards formulated by the provincial drug supervision and administration departments will be abolished
.
According to statistics, as of now, as of September 2022, the State Pharmacopoeia Commission has announced 200 national standard varieties of traditional Chinese medicine formula granules, and 69 varieties are in the publicity period
.
There are about 400 to 600 varieties commonly used in traditional Chinese medicine formula granules, and it is expected that the comprehensive formulation of standards will need to be steadily implemented
.
On August 31 this year, the National Medical Insurance Bureau also issued the "Notice on Printing and Distributing the Unified Coding Rules and Methods of Medical Insurance Chinese Medicine Formula Granules", which clearly stated that on the basis of the coding rules for Chinese medicine tablets, the coding rules of Western medicine and proprietary Chinese medicines were used to formulate the code of Chinese medicine formula granules, which is considered by the industry to be an important promotion of the unified standard of traditional Chinese medicine formulas, which is conducive to the promotion of Chinese medicine formula granules in hospitals, which will further promote the growth of the industry scale and is conducive to supervision.
Ensuring that patients can safely and effectively use Chinese medicine formula granules is a win-win
for countries, enterprises and patients.
The industry believes that the traditional Chinese medicine formula granules relative policy immunity, under the normalization of collection, is expected to gradually replace the market share of drinking tablets and proprietary Chinese medicines in medical institutions, the current market space of traditional Chinese medicine granules in China is only 20 billion, and it is expected that the CAGR of the next annual compound growth rate will be more than 30%, and the market size
of 200 billion yuan will be 10 years later.
Disclaimer: Under no circumstances does the information herein or the opinions expressed in this article constitute investment advice
to any person.